文献检索

查找使用阿拉丁产品的科研文献

检索与阿拉丁产品相关的同行评审论文、DOI、PubMed 编号、期刊、作者、CAS 号及研究领域。

科研影响力快照

与阿拉丁产品相关的已发表科研成果

在搜索之前,这些指标可帮助访客快速了解产品关联科研的规模与质量。

346,364+ SCI 论文 与阿拉丁产品引用相关
2,295,288.15 总影响因子 匹配文献记录中影响因子的总和
81.20 最高期刊影响因子 匹配期刊中的最高 IF
6.63 平均期刊影响因子 匹配文献的平均 IF

参考指标 指标基于阿拉丁文献引用数据库及期刊影响因子记录。文献关联仅供科研参考,请以原始文献为准。

热门产品

视图 列表 网格

4 项

设置提升方向
PVP-K30
MOLECULES · 2024 ·Vol. 29 ·期 3 ·715 · IF 4.2

The Fabrication, Drug Loading, and Release Behavior of Porous Mannitol

Zhe Li,Xiaosui Luo,Qiong Li,Zhengji Jin,Abid Naeem,Weifeng Zhu,Lihua Chen,Yi Feng,Liangshan Ming

Porous materials are widely used as an effective strategy for the solubilization of insoluble drugs. In order to improve the solubility and bioavailability of low water-solubility drugs, it is necessary to prepare porous materials. Mannitol is one of the most popular excipients in food and drug formulations. In this study, porous mannitol was investigated as a drug carrier for low water solubility drugs. Its fabrication, drug loading, and drug release mechanisms were investigated. Porous mannitol was fabricated using the co-spray–antisolvent process and utilizing polyvinylpyrrolidone K30 (PVP K30) as the template agent. Porous mannitol particles were prepared by changing the proportion of the template agent, spraying the particles with mannitol, and eluting with ethanol in order to regulate their pore structure. In subsequent studies, porous mannitol morphology and characteristics were determined systematically. Furthermore, curcumin and ibuprofen, two poorly water-soluble drugs, were loaded into porous mannitol, and their release profiles were analyzed. The results of the study indicated that porous mannitol can be prepared using PVP K30 as a template and that the amount of template agent can be adjusted in order to control the structure of the porous mannitol. When the template agent was added in amounts of 1%, 3%, and 5%, the mannitol pore size increased by 167.80%, 95.16%, and 163.98%, respectively, compared to raw mannitol. Molecular docking revealed that mannitol and drugs are adsorbents and adhere to each other by force interaction. The cumulative dissolution of curcumin and ibuprofen-loaded porous mannitol reached 69% and 70%, respectively. The release mechanism of curcumin and ibuprofen from drug-loaded mannitol was suitable for the Korsmeyer–Peppas kinetic model. In summary, the co-spray–antisolvent method proved effective in fabricating porous materials rapidly, and porous mannitol had a remarkable effect on drug solubilization. The results obtained are conducive to the development of porous materials.

CAS / MDL: 7758-02-3
研究领域: 药剂学 · 材料科学
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
JOURNAL OF HAZARDOUS MATERIALS · 2011 · IF 3.723

Removal of tetracycline from aqueous solutions using polyvinylpyrrolidone (PVP-K30) modified nanoscale zero valent iron

Hua Chen,Hanjin Luo,Yuecun Lan,Tingting Dong,Bingjie Hu,Yiping Wang

The interactions of tetracycline (TC) with nanoscale zerovalent iron (NZVI) modified by polyvinylpyrrolidone (PVP-K30) were investigated using batch experiments as a function of reactant concentration, pH, temperature, and competitive anions. Transmission electron micrographs (TEM), BET surface area and Zeta (ζ)-potential analyses indicated that the mean particle size was 10–40   nm with a surface area of 36.90   m 2 /g, and a iso-electric point of PVP-NZVI was 7.2. The results of X-ray diffraction (XRD) and high-resolution X-ray photoelectron spectroscopy (HR-XPS) of modified nanoscale zerovalent iron (PVP-NZVI) revealed that the iron nanoparticles likely have a core of zero-valent iron (Fe 0 ), while a shell is largely made of iron oxides . Degradation of TC was strongly dependent on pH and temperature. The presence of silicate and phosphate strongly inhibited the removal of TC, whereas acetate and sulfate only caused slight inhibition. LC–MS analysis of the treated solution showed that the degradation products from TC resulted from the removal of functional groups from the TC ring. The degradation products were detected both in the treated solution (initial pH of 3.0 and 6.5) and on the surface of PVP-NZVI after 4-h interaction, indicating that PVP-NZVI can adsorb both TC and its degradation products.

CAS / MDL: 25249-54-1 9003-39-8
研究领域: 环境科学 · 材料科学
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
PHARMACEUTICAL CHEMISTRY JOURNAL · 2024 ·Vol. 57 ·期 10 ·1627-1636 · IF 0.8

Ternary Solid Dispersion of Celecoxib Produced by the Solvent Method with Improved Solubility and Dissolution Properties

Liu Lang,Ouyang Fenfen,Li Ting,Wen Min,Zha Guodong,Chen Libo,Fu Xue,Zhu Li qing

Celecoxib, the first cyclooxygenase-2 selective nonsteroidal anti-inflammatory drug, has a wide range of pharmacological effects, including anti-inflammatory, antirheumatic and antitumor effects. However, celecoxib’s poor solubility severely limits its clinical application. Thus, a novel ternary solid dispersion system was developed using PVP K30 and hydroxypropyl-β-cyclodextrin (HPβCD) as carrier materials in order to improve its solubility and dissolution behavior. The solid dispersion system was characterized by SEM, XRD, FT-IR, DSC, in vitro dissolution, saturated solubility, and contact angle test; the stability of the samples under extreme environments was investigated as well. The results showed that the novel ternary solid dispersion doped with PVP K30 and HPβCD has enhanced solubility around 6.28-fold, an almost 13.94-fold increase in the dissolution rate (120 min) compared with celecoxib’s active pharmaceutical ingredient. The substantial improvement in its dissolution performance is attributed to the fact that celecoxib is dispersed in the carrier material in an amorphous form and has hydrogen bonding interactions with the carrier materials. In addition, the improvement of wettability is one of the reasons for its increased solubility. In conclusion, the combination of PVP K30 and HPβCD can significantly improve the solubility of celecoxib and this novel solid dispersion system provides new ideas and methods to further improve the solubility of insoluble drugs.

研究领域: 药剂学 · 药物技术 · 药物传递 · 材料科学 · 生物药剂学
✓ 已验证 DOI 高影响因子
查看原文 查看 PubMed
BIOPHARMACEUTICS & DRUG DISPOSITION · 2021 ·Vol. 42 ·期 9 ·435-443 · IF 1.627

Evaluation on absorption risks of amentoflavone after oral administration in rats

Hui Qiu,Zhengbing Guo,Qian Xu,Shengfang Mao,Wenming Wu

The present study was aimed to systemically assess the absorption risks of amentoflavone (AMF). Physicochemical properties of AMF were evaluated using in vitro assays including water solubility and stability in both simulated gastric and intestinal fluids, as well as logD, pka and permeability studies in a monolayer Caco-2 model. The results together suggested that AMF was a compound with moderate intestinal absorption and the poor solubility was the key rate-limiting step for the oral absorption of AMF, and PVP-K30 were thus used as a solubilizer to improve its solubility and oral bioavailability. Furthermore, studies on pharmacokinetics and biliary excretion of AMF with tween 80 or PVP-K30 were performed after oral administration, and the results showed that the percentage of AMF conjugates in bile was determined up to be 96.73% and no AMF conjugates were detected in rat plasma. The above results revealed that the poor oral absorption of AMF may probably be attributed to the low solubility, high level of metabolism and hepatic first-pass effects. The relative bioavailability of AMF solubilized by PVP-K30 was about 2-fold than that of AMF suspended in 1% tween 80. The present study may help provide scientific insights to guide the rational design of AMF into more efficient formulation systems.

CAS / MDL: 64-18-6
研究领域: 药理学 · 药物递送系统 · 药剂学
✓ 已验证 产品关联 DOI PubMed 高影响因子
查看原文 查看 PubMed
已复制

文献关联基于可获得的产品、CAS、DOI 及引用记录。收录不代表作者或出版方对阿拉丁产品的背书,请以原始文献为准。